Transplantation of pediatric en block kidneys under FK 506 immunosuppression by Darras, FS et al.
Transplantation of Pediatric En Bloc Kidneys Under·· 
FK 506 Immunosuppression 
F.S. Darras. M.L. Jordan. R. Shapiro. R. Sundberg, V.P. Scantlebury, C.W.B. Jensen, T.R. Hakala, 
and T.E. Starzl 
THE use of kidneys from pediatric donors has been 
controversial because of reponed high rates of graft 
loss from technical and immunologic complications. 1-3 FK 
506 has been shown to be an effective immunosuppressive 
agent in clinical trials in liver transplantation and in recip· 
ients of adult cadaver kidneys.4.5 We repon herein our 
experience with FK 506 as primary immunosuppression in 
39 patients transplanted with en bloc kidneys from young 
pediatric donors under 4 years of age. 
MATERIALS AND METHODS 
All kidneys were harvested en bloc with an intact segment of 
infrarenal aorta and vena cava. the cephalad ends of both closed 
with polypropylene suture. The inferior ends of the donor aorta 
and vena cava were anastomosed end-ta-side to the recipient's 
external iliac vessels. All ureters were reimplanted extravesically. 
Donors ranged in age from 4 to 48 months (mean 19.8 + 4.9 
months, median 20 months). weighing 6.4 to 17.7 kg (mean 11.6 + 
2.6 kg, median 1l.8 kg), with mean tenninal BUN/creatinine of 
1110.4. All patients received FK 506 and steroids without lmman. 
RESULTS 
Overall patient and graft survival rates are 92% and 74%, 
respectively. with a mean follow-up of II months (range 6 
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Table 1. FK 506 and Pediatric En Bloc Kidneys: Patients With Functioning GI1Ifta 
PI8drilone' 
Date of Operabon Trll/'lllPlllllt No. PRA(%) Rejection Donor Age (montI\S) SCR' (mglCIL) FK 1508' (mgtl(g) (119'd) 
10126189 2 23 No 20 1.5 .14B10 0 
11119/89 92 Yes 30 1.1 .1e BID 20 
2116190 0 Yes 18 2.1 .05 BID 5 
2116190 23 No 16 0.9 .06 BID 0 
2123190 0 Yes 21 1.2 .07 BID 7.5 
2126/90 0 No 4 1.4 .15 BID 10 
3/13190 7 No 20 1.9 .16 BID 0 
4/20190 1 7 No 16 1.6 .15 BID 0 
519190 2 7 Yes 24 1.7 .03 BID 0 
6/3190 13 No 22 1.1 .16B10 0 
7/13190 0 No 10 1.4 .04 BID 0 
7/25190 0 Yes 30 0.9 .17 BID 10 
8/16190 0 No 24 1.2 .08 BID 5 
8/29190 3 Yes 30 1.6 .10 BID 10 
8I30I9O 0 No 12 0.5 .13 BID 0 
9/10190 0 Yes 18 1.1 .18 BID 0 
9/14/90 0 No 36 1.5 .12 BID 0 
1014190 0 Yes 22 1.7 .13 BID 10 
10/10190 0 No 20 1.0 .18 BID 0 
10118190 64 Yes 30 0.8 .24 BID 10 
1117190 23 Yes 36 2.0 .10 BID 0 
11/18190 1.5 Yes 31 1.7 .07 BID 7.5 
11I20I90 1.7 No 17 1.2 .16B10 5 
11126190 1 3 Yes 14 2.1 .12T10 5 
12122J9O 1 59 No 9 1.4 .12 BID 7.5 
12129190 2 57 Yes 17 1.6 .18 BID 7.5 
1131191 0 No 7 2.0 .15 BID 5 
1/4191 0 Yes 12 2.3 .14B10 7.5 
1120/91 3 No 8 1.7 .17 BID 0 
• Aliall foUow.up (median 11 monIhI). 
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Table 2. CompllClltlons and cau ... of Graft Lo .. 
• Death (n = 3) 
Cardiac arrest (n = 2) 
TB 
• Anatomic complications (n = 3) 
Acute technical venous thrombosis (n = 1) 
Venous thrombosis from severe rejection (n = 1) 
Mycotic arterial anastomotic aneurysm (n = 1) 
• Irreversible acute rejection (n = 1) 
• Chronic rejection (n = 2) 
• Withdrawal of immunosuppression (TB) (n = 1) 
• Urologic complications (n = 0) 
to 21). There were 3 patient deaths. 2 due to cardiac arrest. 
and 1 due to TB. The clinical characteristics of the 29 
patients who have functioning grafts are summarized in 
Table 1. Thirteen of these 29 patients (45%) are currently 
on FK S06 monotherapy, taking no prednisone. Neither 
prior transplantation. degree of HLA matching or mis-
matching, nor PRA altered graft survival. Donor age did 
not affect graft survival or function. In a subgroup of grafts 
from donors under 1 year of age (n = 9), graft survival is 
78% without any technical complications, and the mean 
serum creatinine I.S mgldL. Table 2 summarizes the 
complications and causes of graft loss. There were no 
urologic complications. Twenty-one patients were diag-
nosed with rejection. Two were not treated because of 
tuberculosis, 2 grafts were lost to early acute rejection. and 
2 were lost to chronic rejection at 12 months. The other 15 
patients had successful reversal of rejection, and have a 
mean serum creatinine of 1.6 ± 0.6. 
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DISCUSSION 
This report demonstrates satisfactory earty results using 
kidneys en bloc from young pediatric cadaver donors with 
FK S06 and low-dose steroids. The 29 functioning grafts 
continue to provide renal function with mean follow-up 
approaching 1 year. Significant is the absence of any 
urologic complications using en bloc kidneys from even 
the smallest donors. The rapid taper of prednisone may be 
an important advantage of FK S06 in recipients of kidneys 
from small donors where problems with healing could lead 
to significant technical complications. 
We conclude that transplanting kidneys en bloc from 
young donors under age 4 can provide excellent renal 
function with good rates of graft survival and acceptable 
complication rates. Use of these small kidneys may be an 
important factor toward increasing the donor pool. In 
addition. FK S06 appears to be an appropriate immuno-
suppressive agent in this setting. permitting excellent renal 
function with minimal toxicity. and the ability to use little 
or no steroids. 
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